Exploring the nasal microbiome's role in diseases like chronic rhinosinusitis and COVID-19

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the nasal microbiome across different patient groups, including healthy individuals and those with olfactory dysfunction related to COVID-19 and chronic rhinosinusitis. It employs case-control and longitudinal cohort designs, collecting microbiome samples from the nasal cavity and oral pharynx for analysis using next-generation sequencing. The study aims to understand how the nasal microbiome differs among these groups and its potential implications for treatment and diagnosis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Exclusion Criteria:

* Does not wish to participate in study

Where it's running

• Ear, Nose and Throat Department, HEV
  Holstebro, Central Jutland, Denmark Recruiting

Study contacts

• Principal investigator: Laura Marie Aalkjær Danielsen — student
• Study coordinator: Laura Marie Aalkjær Danielsen
• Email: lauraaalkjaer@hotmail.com
• Phone: +4542714748

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) in Adults

  This study tests and compares the immune responses and tolerability of the latest COVID-19 vaccines from Novavax and Pfizer/BioNTech in adults at risk for severe COVID-19.

  Recruiting Phase 4 Henry M. Jackson Foundation for the Advancement of Military Medicine · Bethesda, Maryland · NCT07287137

• Understanding how brain changes relate to smell disorders over time

  This small, year-long study tests how brain activity and smell-related inflammation relate to different smell disorders in adults.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07149428

• Olfactory training for smell issues after COVID-19

  This study is testing if a special smell training program can help people who have trouble smelling after having COVID-19 feel better and improve their sense of smell.

  Recruiting Université du Québec à Trois-Rivières · Trois-Rivières, Quebec · NCT05384561

• Omicron-based COVID-19 vaccine with Matrix-M given as a single dose in older adults and high-risk individuals

  A single-dose Omicron-subvariant vaccine with Matrix-M is tested to see if it is safe and can induce an immune response in adults 65+ and in younger adults with conditions that raise the risk of severe COVID-19, who were previously vaccinated.

  Recruiting at 20 sites Phase 4 Sanofi · Fair Oaks, California and 19 other locations · NCT07861542

• Secutrelvir for nonhospitalized COVID-19 in teens and adults

  This study tests whether secutrelvir can help nonhospitalized people with COVID-19 see faster symptom relief compared with a placebo.

  Recruiting Phase 3 Shionogi Inc. · Multiple Locations · NCT07746544

• Virological Monitoring of Seasonal Respiratory Infections in France

  This project tests how often common respiratory viruses show up in patients seen by primary care doctors in metropolitan France during the fall and winter.

  Recruiting Institut National de la Santé Et de la Recherche Médicale, France · Paris · NCT07599449

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.